Pro-Dex, Inc.
PDEX Healthcare Medical Instruments & Supplies
Pro-Dex, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $77.5 million, up 16.5% from fiscal 2025. In the quarter to June 2026, revenue grew 16.7%, EPS grew 143.2%, free cash flow fell 79.0% and total debt rose 43.5%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
Follow PDEX
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
10.55 | 8.82 | 10.98 | 9.34 |
Receivables |
18.34 | 18.15 | 19.77 | 21.83 | |
Inventory |
21.56 | 21.71 | 22.36 | 21.46 | |
Total current assets |
50.72 | 49.19 | 53.71 | 53.25 | |
Property, Plant, Equpment (Net) |
11.01 | 10.77 | 11.52 | 11.34 | |
Long-Term Investments |
0.15 | 0.14 | 0.46 | 0.50 | |
Goodwill and Intangible Assets (Total) |
0.02 | 0.01 | 7.24 | 7.21 | |
Long Term Assets (Tax, Deferred) |
1.42 | 1.28 | 1.28 | 1.54 | |
Long-term assets (Other) |
0.04 | 0.04 | 0.06 | 0.06 | |
Total non-current assets |
13.58 | 13.07 | 21.27 | 21.26 | |
Total Assets |
64.30 | 62.26 | 74.98 | 74.51 | |
Notes Payable |
4.61 | 2.47 | 4.19 | 4.21 | |
Accounts Payable |
3.97 | 4.11 | 5.25 | 4.26 | |
Accrued Expenses |
4.13 | 4.26 | 4.32 | 4.37 | |
Current Part of Taxes to Pay |
0.78 | 1.20 | 0.74 | 0.12 | |
Current Revenue (Deferred) |
0.12 | 0.16 | 0.14 | 0.03 | |
Total current liabilities |
13.60 | 12.20 | 14.64 | 12.98 | |
Long Term Debt (Total) |
8.63 | 8.01 | 14.31 | 13.27 | |
Total non-current liabilities |
9.18 | 8.42 | 15.14 | 13.89 | |
Total liabilities |
22.79 | 20.63 | 29.78 | 26.88 | |
Common Stock (Net) |
0.91 | — | — | — | |
Retained Earnings |
40.61 | 41.63 | 45.20 | 47.63 | |
Common Equity (Total) |
41.51 | 41.63 | 45.20 | 47.63 | |
Shareholders Equity (Total) |
41.51 | 41.63 | 45.20 | 47.63 | |
Shareholders Equity and Liabilities (Total) |
64.30 | 62.26 | 74.98 | 74.51 | |
Shares (Common) |
3.26 | 3.21 | 3.20 | 3.19 | |
Shareholders Equity (Tangible) |
41.49 | 41.62 | 37.96 | 40.42 | |
Net Debt |
(1.92) | (0.81) | 3.33 | 3.92 | |
Total Debt |
8.63 | 8.01 | 14.31 | 13.27 |